• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Why some and not others? Understanding vascular phenotypes in genetic developmental lung diseases.为什么是某些而不是其他的?了解遗传性发育性肺部疾病中的血管表型。
Curr Opin Pediatr. 2025 Jun 1;37(3):278-288. doi: 10.1097/MOP.0000000000001459. Epub 2025 Mar 28.
2
TBX4 variants and pulmonary diseases: getting out of the 'Box'.TBX4 变异体与肺部疾病:走出“盒子”。
Curr Opin Pulm Med. 2020 May;26(3):277-284. doi: 10.1097/MCP.0000000000000678.
3
Decreased Level of TMEM100 in Neonates With Lethal Lung Developmental Disorders due to Abnormalities in SHH-FOXF1 and TBX4-FGF10 Signaling Pathways.由于SHH - FOXF1和TBX4 - FGF10信号通路异常导致致命性肺发育障碍的新生儿中TMEM100水平降低。
Am J Med Genet A. 2025 Aug;197(8):e64071. doi: 10.1002/ajmg.a.64071. Epub 2025 Mar 27.
4
Complex Compound Inheritance of Lethal Lung Developmental Disorders Due to Disruption of the TBX-FGF Pathway.TBX-FGF 通路破坏导致致死性肺发育障碍的复杂复合遗传。
Am J Hum Genet. 2019 Feb 7;104(2):213-228. doi: 10.1016/j.ajhg.2018.12.010. Epub 2019 Jan 10.
5
Potential interactions between the TBX4-FGF10 and SHH-FOXF1 signaling during human lung development revealed using ChIP-seq.利用 ChIP-seq 揭示人类肺发育过程中 TBX4-FGF10 和 SHH-FOXF1 信号之间的潜在相互作用。
Respir Res. 2021 Jan 21;22(1):26. doi: 10.1186/s12931-021-01617-y.
6
The biology of the ABCA3 lipid transporter in lung health and disease.ABCA3脂质转运蛋白在肺部健康与疾病中的生物学特性
Cell Tissue Res. 2017 Mar;367(3):481-493. doi: 10.1007/s00441-016-2554-z. Epub 2016 Dec 26.
7
FOXF1 transcription factor is required for formation of embryonic vasculature by regulating VEGF signaling in endothelial cells.FOXF1转录因子通过调节内皮细胞中的VEGF信号传导来参与胚胎血管系统的形成。
Circ Res. 2014 Sep 26;115(8):709-20. doi: 10.1161/CIRCRESAHA.115.304382. Epub 2014 Aug 4.
8
First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease.TBX4 综合征的首个性状-基因型研究:导致肺部疾病的功能获得性突变。
Am J Respir Crit Care Med. 2022 Dec 15;206(12):1522-1533. doi: 10.1164/rccm.202203-0485OC.
9
Ultrastructural characterization of genetic diffuse lung diseases in infants and children: a cohort study and review.婴幼儿和儿童遗传性弥漫性肺疾病的超微结构特征:一项队列研究及综述
Ultrastruct Pathol. 2013 Oct;37(5):356-65. doi: 10.3109/01913123.2013.811454.
10
Pulmonary phenotypes associated with genetic variation in telomere-related genes.与端粒相关基因遗传变异相关的肺部表型。
Curr Opin Pulm Med. 2018 May;24(3):269-280. doi: 10.1097/MCP.0000000000000475.

本文引用的文献

1
Loss of Affects Postnatal Lung Development and Predisposes to Pulmonary Hypertension.[具体缺失内容]影响出生后肺发育并易患肺动脉高压。
Am J Respir Cell Mol Biol. 2025 Mar 19. doi: 10.1165/rcmb.2024-0459OC.
2
Efficacy and safety of CFTR modulators in patients with interstitial lung disease caused by ABCA3 transporter deficiency.CFTR调节剂在ABCA3转运蛋白缺乏所致间质性肺疾病患者中的疗效与安全性。
ERJ Open Res. 2025 Mar 3;11(2). doi: 10.1183/23120541.00701-2024. eCollection 2025 Mar.
3
PRDM3/16 regulate chromatin accessibility required for NKX2-1 mediated alveolar epithelial differentiation and function.PRDM3/16调节NKX2-1介导的肺泡上皮分化和功能所需的染色质可及性。
Nat Commun. 2024 Sep 16;15(1):8112. doi: 10.1038/s41467-024-52154-3.
4
An interdisciplinary consensus approach to pulmonary hypertension in developmental lung disease.发育性肺疾病相关肺动脉高压的跨学科共识方法。
Eur Respir J. 2024 Sep 26;64(3). doi: 10.1183/13993003.00639-2024. Print 2024 Sep.
5
Early human fetal lung atlas reveals the temporal dynamics of epithelial cell plasticity.早期人类胎儿肺图谱揭示了上皮细胞可塑性的时间动态。
Nat Commun. 2024 Jul 13;15(1):5898. doi: 10.1038/s41467-024-50281-5.
6
Identification of endothelial and mesenchymal FOXF1 enhancers involved in alveolar capillary dysplasia.鉴定参与肺泡毛细血管发育不良的内皮和间充质 FOXF1 增强子。
Nat Commun. 2024 Jun 19;15(1):5233. doi: 10.1038/s41467-024-49477-6.
7
The biophysical function of pulmonary surfactant.肺表面活性物质的生物物理功能。
Biophys J. 2024 Jun 18;123(12):1519-1530. doi: 10.1016/j.bpj.2024.04.021. Epub 2024 Apr 25.
8
Diminished 100 Expression in a Newborn With Acinar Dysplasia and a Novel Variant: A Case Report.新生儿腺泡发育不良伴 100 表达减少及新型变异:病例报告。
Pediatr Dev Pathol. 2024 May-Jun;27(3):255-259. doi: 10.1177/10935266231213464. Epub 2023 Dec 3.
9
Unique Pulmonary Hypertensive Vascular Diseases Associated with Heart and Lung Developmental Defects.与心肺发育缺陷相关的独特肺动脉高压性血管疾病。
J Cardiovasc Dev Dis. 2023 Aug 3;10(8):333. doi: 10.3390/jcdd10080333.
10
Variants in FGF10 cause early onset of severe childhood interstitial lung disease: A detailed description of four affected children.FGF10 变异导致严重儿童间质性肺病的早发性发作:四名患儿的详细描述。
Pediatr Pulmonol. 2023 Nov;58(11):3095-3105. doi: 10.1002/ppul.26627. Epub 2023 Aug 10.

为什么是某些而不是其他的?了解遗传性发育性肺部疾病中的血管表型。

Why some and not others? Understanding vascular phenotypes in genetic developmental lung diseases.

作者信息

Steffes Lea C, Kumar Maya E, Varghese Nidhy P

机构信息

Division of Pulmonology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

Division of Pulmonology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

出版信息

Curr Opin Pediatr. 2025 Jun 1;37(3):278-288. doi: 10.1097/MOP.0000000000001459. Epub 2025 Mar 28.

DOI:10.1097/MOP.0000000000001459
PMID:40172258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12113387/
Abstract

PURPOSE OF REVIEW

Pulmonary vascular disease is more common in certain genetic developmental lung disorders. This review synthesizes clinical descriptions, molecular analyses, and single-cell transcriptional data to build a conceptual framework to help understand why some variants affect the vasculature while others primarily manifest with parenchymal disease.

RECENT FINDINGS

Genes predominantly expressed in endothelial and mesenchymal compartments ( TBX4 , FGF10 , FOXF1 , KDR ) commonly present with both parenchymal and pulmonary vascular disease, while epithelial-restricted genes ( SFTPC , ABCA3 , NKX2.1 ) typically manifest as parenchymal disease. Single-cell analyses reveal that compartment-specific expression patterns correlate with clinical phenotypes. Phenotypic variability, even among individuals sharing identical variants, suggests complex interactions between genetic modifiers, epigenetic factors, and developmental processes that remain poorly understood.

SUMMARY

Compartment-specific gene expression patterns fundamentally underlie the differential presence of vascular phenotypes in DEVLDs. Genetic advances and single cell technologies have revolutionized our understanding of these disorders, but we are in the early stages of translating this knowledge into meaningful clinical advances. Future efforts must bridge this gap to transform clinical care from supportive to targeted, disease-modifying treatment based on cell-specific molecular mechanisms.

摘要

综述目的

肺血管疾病在某些遗传性发育性肺部疾病中更为常见。本综述综合了临床描述、分子分析和单细胞转录数据,构建了一个概念框架,以帮助理解为什么有些变异会影响脉管系统,而另一些变异主要表现为实质性疾病。

最新发现

主要在内皮和间充质区室表达的基因(TBX4、FGF10、FOXF1、KDR)通常同时伴有实质性疾病和肺血管疾病,而上皮限制性基因(SFTPC、ABCA3、NKX2.1)通常表现为实质性疾病。单细胞分析表明,区室特异性表达模式与临床表型相关。即使在具有相同变异的个体中,表型变异性也表明遗传修饰因子、表观遗传因素和发育过程之间存在复杂的相互作用,而我们对此仍知之甚少。

总结

区室特异性基因表达模式从根本上是发育性遗传性肺部疾病中血管表型差异存在的基础。遗传学进展和单细胞技术彻底改变了我们对这些疾病的理解,但我们仍处于将这些知识转化为有意义的临床进展的早期阶段。未来的努力必须弥合这一差距,将临床护理从支持性治疗转变为基于细胞特异性分子机制的靶向性、疾病修饰性治疗。